Skip to main content
SpringerLink
Log in

Benchmarking the scientific output of the Innovative Medicines Initiative

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lim, M.D. Sci. Transl. Med. 6, 242cm6 (2014).

    Article  PubMed  Google Scholar 

  2. Printz, C. Cancer 119, 1925–1927 (2013).

    Article  PubMed  Google Scholar 

  3. Goldman, M., Seigneuret, N. & Eichler, H.-G. Nat. Rev. Drug Discov. 14, 1–2 (2015).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Innovative Medicines Initiative, Brussels, Belgium

    Magda Gunn

  2. Fastercures, Center of the Milken Institute, Washington, DC, USA

    Mark Lim

  3. Thomson Reuters, New York, New York, USA

    Didi Cross

  4. Université Libre de Bruxelles, Brussels, Belgium

    Michel Goldman

Authors
  1. Magda Gunn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Didi Cross
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michel Goldman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Magda Gunn.

Ethics declarations

Competing interests

M.G. is scientific officer at the program office of IMI. D.C. is at Thomson Reuters, which conducted the bibliometric analysis for IMI. M.G. is the former executive director of IMI.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gunn, M., Lim, M., Cross, D. et al. Benchmarking the scientific output of the Innovative Medicines Initiative. Nat Biotechnol 33, 811–812 (2015). https://doi.org/10.1038/nbt.3305

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3305

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation